[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Heska Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Heska Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hester Biosciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hester Biosciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hi Tech Pharmacal Co. Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hi Tech Pharmacal Co. Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

High Tech Pharm Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

High Tech Pharm Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Highnoon Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Highnoon Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hikma Pharmaceuticals plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hikma Pharmaceuticals plc Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hindustan Bio Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hindustan Bio Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hiran Orgochem Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hiran Orgochem Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hiru Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hiru Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hisamitsu Pharmaceutical Co. Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hisamitsu Pharmaceutical Co. Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Histostem Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Histostem Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Holista CollTech Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Holista CollTech Limited Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hospira Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hospira Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hovid Berhad Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hovid Berhad Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

HST Global, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

HST Global, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hua Han Bio-Pharmaceutical Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hua Han Bio-Pharmaceutical Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hualan Biological Engineering Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hualan Biological Engineering Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Huazhi Holding (chongqing) Co.,Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Huazhi Holding (chongqing) Co.,Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hubei Guangji Pharmaceutical Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hubei Guangji Pharmaceutical Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Huifeng Bio-Pharmaceutical Technology, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Huifeng Bio-Pharmaceutical Technology, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Human Genome Sciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Human Genome Sciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hunan Hansen Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hunan Hansen Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Huons Global Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Huons Global Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hutchison China MediTech Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hutchison China MediTech Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hwail Pharm Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hwail Pharm Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hybrigenics SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hybrigenics SA Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hyundai Pharm. Ind. Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hyundai Pharm. Ind. Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

IBEX Technologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

IBEX Technologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

iBio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

iBio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

ICAgen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ICAgen Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

iCo Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

iCo Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

ICON plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ICON plc Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 64 pages

Idenix Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Idenix Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Idera Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Idera Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

IDT Australia Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

IDT Australia Limited Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Ildong Holdings Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ildong Holdings Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Illumina Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Illumina Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 86 pages

Ilsung Pharmaceuticals Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ilsung Pharmaceuticals Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Ilyang Pharmaceutical Co., Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ilyang Pharmaceutical Co., Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Immtech Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Immtech Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

ImmuCell Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ImmuCell Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Immune Network Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Immune Network Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Immuno-Biological Laboratories Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Immuno-Biological Laboratories Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

ImmunoBiotics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ImmunoBiotics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

ImmunoCellular Therapeutics, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ImmunoCellular Therapeutics, Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Immunogen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Immunogen Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Immunomedics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Immunomedics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Immunosyn Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Immunosyn Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Immunotech Laboratories, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Immunotech Laboratories, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

ImmunoVaccine Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ImmunoVaccine Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers